JP5171073B2 - 循環器系疾患の予防又は治療のための医薬組成物 - Google Patents

循環器系疾患の予防又は治療のための医薬組成物 Download PDF

Info

Publication number
JP5171073B2
JP5171073B2 JP2007061438A JP2007061438A JP5171073B2 JP 5171073 B2 JP5171073 B2 JP 5171073B2 JP 2007061438 A JP2007061438 A JP 2007061438A JP 2007061438 A JP2007061438 A JP 2007061438A JP 5171073 B2 JP5171073 B2 JP 5171073B2
Authority
JP
Japan
Prior art keywords
blood
loxoprofen
administration
pharmaceutical composition
nitric oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007061438A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007284424A (ja
JP2007284424A5 (https=
Inventor
保博 鳥住
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Daiichi Sankyo Healthcare Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Daiichi Sankyo Healthcare Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd, Daiichi Sankyo Healthcare Co Ltd filed Critical Daiichi Sankyo Co Ltd
Priority to JP2007061438A priority Critical patent/JP5171073B2/ja
Publication of JP2007284424A publication Critical patent/JP2007284424A/ja
Publication of JP2007284424A5 publication Critical patent/JP2007284424A5/ja
Application granted granted Critical
Publication of JP5171073B2 publication Critical patent/JP5171073B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2007061438A 2006-03-23 2007-03-12 循環器系疾患の予防又は治療のための医薬組成物 Expired - Fee Related JP5171073B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007061438A JP5171073B2 (ja) 2006-03-23 2007-03-12 循環器系疾患の予防又は治療のための医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006081486 2006-03-23
JP2006081486 2006-03-23
JP2007061438A JP5171073B2 (ja) 2006-03-23 2007-03-12 循環器系疾患の予防又は治療のための医薬組成物

Publications (3)

Publication Number Publication Date
JP2007284424A JP2007284424A (ja) 2007-11-01
JP2007284424A5 JP2007284424A5 (https=) 2010-03-25
JP5171073B2 true JP5171073B2 (ja) 2013-03-27

Family

ID=38756530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007061438A Expired - Fee Related JP5171073B2 (ja) 2006-03-23 2007-03-12 循環器系疾患の予防又は治療のための医薬組成物

Country Status (1)

Country Link
JP (1) JP5171073B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008031164A (ja) * 2006-07-07 2008-02-14 Daiichi Sankyo Healthcare Co Ltd 高尿酸血症又はこれに起因する疾患の予防又は治療のための医薬組成物
JP2023092366A (ja) * 2021-12-21 2023-07-03 小林製薬株式会社 血行促進用組成物

Also Published As

Publication number Publication date
JP2007284424A (ja) 2007-11-01

Similar Documents

Publication Publication Date Title
Mehta et al. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
JP5134916B2 (ja) 心血管イベント発症予防用組成物
JP2012193211A (ja) 心血管イベント発症予防用組成物
US20080166419A1 (en) Krill oil compositions
JP5171073B2 (ja) 循環器系疾患の予防又は治療のための医薬組成物
US20140200204A1 (en) Combinations of corroles and statins
JP5226980B2 (ja) ＨＭＧ−ＣｏＡリダクターゼ阻害剤、トコフェロール類及びＣｏＱ１０を含有する医薬組成物
WO2005084392A2 (en) 4-methylpyrazole formulations for inhibiting ethanol intolerance
US11602510B2 (en) Agent for use in the treatment of dyslipidemia
ES2342885T3 (es) Composiciones farmaceuticas de liberacion controlada estables que contienen fenofibrato y pravastatina.
US11357746B2 (en) Method for enhancing energy production and metabolism in cells
US20060009486A1 (en) Composition and method for treatment and prevention of coronary artery disease
US20110269755A1 (en) Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
CN102652746A (zh) 一种含有氯吡格雷及其药学上可接受的盐的药物组合物及其制备方法
CA2534660A1 (en) Single unit pharmaceutical composition comprising a mixture of a fibrate and an homocysteine reducing agent
JP4949661B2 (ja) ＨＭＧ−ＣｏＡリダクターゼ阻害剤とグルタチオンを含有する医薬組成物
JP2007513991A (ja) メタボリック症候群の処置のためのスタチンの使用
RU2663460C2 (ru) Комбинированный препарат, содержащий валсартан и розувастатин кальция и способ его изготовления
JP4896501B2 (ja) 血中遊離脂肪酸低下作用を有する医薬組成物
Ballantyne et al. Fluvastatin reduces cardiac mortality in patients with coronary heart disease
JP4751257B2 (ja) 心血管イベント発症予防用組成物
JP2005225870A (ja) 血管内皮性酸化窒素の合成促進及び／又は内皮性酸化窒素血中濃度の維持・向上剤
Andersson Pharmacokinetics of omeprazole in man with special reference to single and repeated administration, drug interactions, and polymorphic metabolism.
CN113288894A (zh) 一种新型的预防和治疗心脏病的药物
JP2007106703A (ja) 血管障害の予防および治療組成物

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100209

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20100209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120731

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120927

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121031

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121127

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121217

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121225

R150 Certificate of patent or registration of utility model

Ref document number: 5171073

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees